Overview

Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease

Status:
Terminated
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The aim of this therapeutic trial is to compare the response of subjects with active IBD to daily intravenous dexamethasone versus the response to daily intravenous methylprednisolone.
Phase:
N/A
Details
Lead Sponsor:
University of Chicago
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate